Abstract
Abstract
Background: Renoprotective therapies are aimed at slowing renal function decline and are registered for preventing End-Stage-Renal-Disease (ESRD). ESRD (renal replacement therapy [RRT]: dialysis or renal transplantation) is considered an objective and clinically relevant hard endpoint in nephrology trials since it reflects the failure of proper kidney function. However, the initiation
... read more